A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dobutamine
Sofosbuvir
Dexamethasone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dobutamine
Afatinib
Dexamethasone may decrease the excretion rate of Afatinib which could result in a higher serum level.
Dobutamine
Revefenacin
Dexamethasone may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Dobutamine
Talazoparib
Dexamethasone may decrease the excretion rate of Talazoparib which could result in a higher serum level.
Dobutamine
Ombitasvir
Dexamethasone may decrease the excretion rate of Ombitasvir which could result in a higher serum level.
Dobutamine
Fimasartan
Dexamethasone may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Dobutamine
Dolutegravir
Dexamethasone may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Dobutamine
Camptothecin
Dexamethasone may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Dobutamine
Alvocidib
Dexamethasone may decrease the excretion rate of Alvocidib which could result in a higher serum level.
Dobutamine
Hydrocodone
The metabolism of Hydrocodone can be increased when combined with Dexamethasone.
Dobutamine
Pitolisant
The metabolism of Pitolisant can be increased when combined with Dexamethasone.
Dobutamine
Mifamurtide
The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Dexamethasone.
Dobutamine
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Dexamethasone.
Dobutamine
Testosterone undecanoate
The risk or severity of edema formation can be increased when Dexamethasone is combined with Testosterone undecanoate.
Dobutamine
Testosterone cypionate
The risk or severity of edema formation can be increased when Dexamethasone is combined with Testosterone cypionate.
Dobutamine
Methyltestosterone
The risk or severity of edema formation can be increased when Dexamethasone is combined with Methyltestosterone.
Dobutamine
Androstenedione
The risk or severity of edema formation can be increased when Dexamethasone is combined with Androstenedione.
Dobutamine
5-androstenedione
The risk or severity of edema formation can be increased when Dexamethasone is combined with 5-androstenedione.
Dobutamine
Testosterone propionate
The risk or severity of edema formation can be increased when Dexamethasone is combined with Testosterone propionate.
Dobutamine
Prasterone sulfate
The risk or severity of edema formation can be increased when Dexamethasone is combined with Prasterone sulfate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3